A New Approach to Vector-Free CRISPR Editing Starting From Single Cells

Watch Now

Sponsored by:

Cytosurge AG
Date:
September 23, 2024
Time (ET):
4:00 PM

Webinar Highlights

Recent advancements in gene editing have highlighted the importance of precision and control in the development of genetically modified cell lines. The CellEDIT service leverages a novel vector-free CRISPR editing approach, starting from single cells, to achieve high precision in gene editing. This method has proven effective in complex scenarios, such as multiplexing in CHO cells and executing precise deletions of distinct genomic elements, offering a significant leap forward in the field of genetic research.In this webinar, Dr. Tobias Beyer, Chief Scientific Officer of Cytosurge, provides a detailed overview of the CellEDIT workflow and shows how this approach provides enhanced control over the editing process, supporting more complex CRISPR edits.

By attending this webinar, you'll gain valuable insights into:

  • The scientific principles of the unique vector-free CellEDIT approach, and how it uses intranuclear injection of CRISPR RNPs into single cells to enhance control over the editing process.
  • Case studies demonstrating efficient multiplexing in CHO cells, including simultaneously knocking out 3 genes in a single experiment.
  • Advanced CRISPR editing strategies, such as precise deletions and double guide techniques, and how these innovations can impact your research.

Don't miss this opportunity to gain insights into the vector-free CellEDIT approach and how it can transform your research and accelerate your progress.

Presenters

Tobias Beyer

Cytosurge AG (CellEDIT Service)
CSO / Application Specialist

Dr. Tobias Beyer obtained his PhD in Cell Biology from the ETH Zurich. After a postdoctoral fellowship at the LTRI in Toronto, he returned to ETH Zurich as junior group leader with Prof. Wutz and Prof. Corn. with combined 20 years of research experience he further established the cell line engineering workflow at the CellEDIT service.

Read More

Sponsor

Cytosurge AG

Cytosurge's CellEDIT service delivers precise, high-quality CRISPR-edited cell lines using a unique vector-free workflow for direct, gentle nuclear injection.

Content Partners

Scientist.com

Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.

We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.

Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

Related Content

Related Content